Results

Our proven
track record.

  • We represented a University in its spinout of a biopharmaceutical company and subsequent $32 million Series A financing, including an agreement granting exclusive rights to acquire the company and its technology.
  • We represented a specialty pharmaceutical client in its collaboration with a Chinese pharmaceutical company to develop and manufacture pharmaceutical products in China.
  • Our lawyers represented a Singapore-based public company in its joint venture with a privately held U.S. company to develop and market hardware and software products for postal, courier, and logistics markets.
  • We have negotiated joint development agreements with US, Swiss, Canadian, and Chinese pharmaceutical companies relating to both new compounds and generic versions of listed drugs on behalf of biotech and specialty pharmaceutical companies.
  • We represented a U.S. manufacturer in a joint venture with a Chinese partner for the construction of a manufacturing facility in Shanghai.
  • We represented a leading Canadian provider of diagnostic imaging technology in negotiating a series of arrangements to distribute its technology in conjunction with the products of the world’s top medical imaging equipment manufacturers.
  • We represented a U.S.-based pharmaceutical company and its India-based subsidiary in numerous licensing and joint venture transactions with major educational and government organizations in India and represented them in its sale to a British entity. Currently, we represent a principal of the acquired entities in a spin out of these entities, which involves among other issues, special purpose financing arranged through an Indian private equity fund and coordinating U.S. and Indian tax and securities laws.
  • Our lawyers represented a venture capital fund in its collaboration with a publicly traded Dutch company and a US executive in developing a web-based gaming site in the United Kingdom.
RESOURCES

Happenings, headlines and insights.
See what’s new at Davis Malm.

View Our Business Resources

Publications

November 2, 2020

Tax-Exempt Entity Retirement Plans and the Tax Consequences of Noncompliance

Read More

Firm Announcements

October 23, 2020

Davis Malm Adds Immigration Attorney Allison Ahern Fillo to Business Law Practice

Read More

Publications

October 20, 2020

Important Changes on the Way for Massachusetts Cannabis Delivery Licenses

Read More

Publications

October 15, 2020

Massachusetts Publishes Proposed Regulations to Establish Delivery License

Read More

Alerts

October 8, 2020

Tax-Exempt Entity 457(b) Plans & the Tax Consequences of Noncompliance

Read More

Alerts

October 2, 2020

Cannabis Control Commission Publishes Proposed Regulations to Establish Wholesale Delivery License

Read More

Publications

August 28, 2020

How Businesses Can Reopen in Compliance With the ADA

Read More

Publications

August 25, 2020

Massachusetts Travels the Long and Winding Road to Social Equity in Cannabis

Read More

Publications

August 13, 2020

New Guidance for Tax-Exempt Organizations: Proposed IRC 4960 Regulations

Read More
Contact Us

Need Business Counsel?

Get in touch
Scroll to Top